Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Aeterna Zentaris (AEZS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 36,004
  • Shares Outstanding, K 16,440
  • Annual Sales, $ 920 K
  • Annual Income, $ -16,800 K
  • 36-Month Beta 0.98
  • Price/Sales 38.12
  • Price/Cash Flow N/A
  • Price/Book 3.05

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.89 +13.76%
on 05/23/18
2.65 -18.87%
on 05/30/18
+0.27 (+14.36%)
since 05/18/18
3-Month
1.12 +91.96%
on 04/04/18
2.65 -18.87%
on 05/30/18
+0.50 (+30.30%)
since 03/19/18
52-Week
0.89 +141.57%
on 06/22/17
3.29 -34.65%
on 07/20/17
+1.19 (+123.96%)
since 06/19/17

Most Recent Stories

More News
Aeterna Zentaris Appoints Olaf Althaus as General Manager and Managing Director of Aeterna Zentaris GmbH

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced that Olaf Althaus has been appointed to the position of General Manager and Managing Director of Aeterna Zentaris GmbH in Frankfurt, Germany, effective...

AEZS.TO : 2.82 (-0.35%)
AEZS : 2.15 (-1.83%)
Mirati Therapeutics (MRTX) Soars: Stock Adds 13.6% in Session

Mirati Therapeutics (MRTX) saw a big move last session, as its shares jumped nearly 14% on the day, amid huge volumes.

AEZS : 2.15 (-1.83%)
MRTX : 50.45 (+2.54%)
VIVUS (VVUS) in Focus: Stock Moves 5.6% Higher

VIVUS (VVUS) was a big mover last session, as the company saw its shares rise nearly 6% on the day.

AEZS : 2.15 (-1.83%)
VVUS : 0.82 (-1.20%)
MiMedx Group (MDXG) Soars: Stock Adds 11.2% in Session

MiMedx Group (MDXG) shares rose more than 11% in the last trading session, amid huge volumes.

MDXG : 5.40 (-1.46%)
AEZS : 2.15 (-1.83%)
Inovio Pharmaceuticals (INO) in Focus: Stock Moves 5.7% Higher

Inovio Pharmaceuticals (INO) was a big mover last session, as the company saw its shares rise nearly 6% on the day.

AEZS : 2.15 (-1.83%)
INO : 4.26 (-3.84%)
Zacks.com highlights: Weight Watchers International, Aeterna Zentaris, TransUnion, Six Flags Entertainment and Johnson Outdoors

Zacks.com highlights: Weight Watchers International, Aeterna Zentaris, TransUnion, Six Flags Entertainment and Johnson Outdoors

SIX : 71.98 (-0.08%)
AEZS : 2.15 (-1.83%)
TRU : 71.78 (+0.38%)
JOUT : 80.03 (-0.16%)
WTW : 100.36 (-0.01%)
5 Top Profitable Stocks With Terrific Growth in the Offing

A company with a high level of profitability is able to meet all its operating and non-operating costs and expenses, and still provides high returns to its investors.

SIX : 71.98 (-0.08%)
AEZS : 2.15 (-1.83%)
TRU : 71.78 (+0.38%)
JOUT : 80.03 (-0.16%)
WTW : 100.36 (-0.01%)
Aeterna Zentaris Announces Results of Annual and Special Shareholders' Meeting

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) announced today at its annual and special shareholders' meeting held on May 8, 2018, that the individuals noted below were elected as directors of the Company....

NVDQ : 11.75 (unch)
AEZS.TO : 2.82 (-0.35%)
AEZS : 2.15 (-1.83%)
NDQ.TO : 14.36 (+0.70%)
CECE : 6.24 (+2.30%)
Aeterna Zentaris Reports First Quarter 2018 Financial and Operating Results

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) today reported financial and operating results for the first quarter ended March 31, 2018.

AEZS.TO : 2.82 (-0.35%)
AEZS : 2.15 (-1.83%)
Aeterna Zentaris to Announce First Quarter 2018 Financial and Operating Results on May 7, 2018

Aeterna Zentaris Inc. (NASDAQ:AEZS) (TSX:AEZS) will announce its first quarter 2018 financial and operating results after market close on Monday, May 7, 2018. The Company will host a conference call to...

AEZS.TO : 2.82 (-0.35%)
AEZS : 2.15 (-1.83%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More Share

Trade AEZS with:

Business Summary

AEterna Zentaris Inc. is a biopharmaceutical company focused on endocrine therapy and oncology. Its lead endocrinology program is a Phase 3 trial in benign prostatic hyperplasia (BPH) with cetrorelix, an LHRH antagonist already marketed for in vitro fertilization under the brand name Cetrotide. The lead...

See More

Key Turning Points

2nd Resistance Point 2.21
1st Resistance Point 2.18
Last Price 2.15
1st Support Level 2.11
2nd Support Level 2.07

See More

52-Week High 3.29
Fibonacci 61.8% 2.37
Last Price 2.15
Fibonacci 50% 2.09
Fibonacci 38.2% 1.81
52-Week Low 0.89

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar